| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.46 | 1e-11 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.44 | 1e-10 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |